Cynapsus Therapeutics (CYNA) Down on FDA Fast-Track

Cynapsus Therapeutics Inc. CYNA shares docked 0.7% to $18.39, after the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for APL-130277, a product candidate for the treatment of OFF episodes in patients with Parkinson's disease. Share volume was 21,000, compared to an all-day average of 64,000